BMRA (BIOMERICA INC)
Insider Trading Activity
Every open-market purchase and sale reported by BMRA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-27 | M. Huff Gary | Director | Buy | — | — |
| 2026-08-27 | ALLEN BARBIERI | Executive Vice Chairman | Buy | — | — |
| 2026-08-27 | DAVID MOATAZEDI | Director | Buy | — | — |
| 2026-08-27 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2026-08-27 | Eric Chin | Director | Buy | — | — |
| 2026-01-28 | Eric Chin | Director | A | — | — |
| 2025-12-31 | Gary Lu | Chief Financial Officer | A | — | — |
| 2025-12-31 | M. Huff Gary | Director | A | — | — |
| 2025-12-31 | Zackary S. Irani | Chief Executive Officer | A | — | — |
| 2025-12-31 | ALLEN BARBIERI | Executive Vice-Chairman | A | — | — |
| 2025-12-31 | DAVID MOATAZEDI | Director | A | — | — |
| 2024-12-17 | DAVID MOATAZEDI | Director | A | — | — |
| 2024-12-17 | Jane Emerson | Director | A | — | — |
| 2024-12-17 | Catherine Coste | Director | A | — | — |
| 2024-12-17 | ALLEN BARBIERI | Executive Vice Chairman | A | — | — |
| 2024-12-17 | Gary Lu | Chief Financial Officer | A | — | — |
| 2024-12-17 | Zackary S. Irani | Chief Executive Officer | A | — | — |
| 2023-12-14 | Catherine Coste | Director | A | — | — |
| 2023-12-14 | Zackary S. Irani | Chief Executive Officer | A | — | — |
| 2023-12-14 | John P. Kenny | Director | A | — | — |
| 2023-12-14 | Gary Lu | Chief Financial Officer | A | — | — |
| 2023-12-14 | DAVID MOATAZEDI | Director | A | — | — |
| 2023-12-14 | ALLEN BARBIERI | Executive Vice Chairman | A | — | — |
| 2023-12-14 | Jane Emerson | Director | A | — | — |
| 2023-12-11 | John P. Kenny | Director | A | — | — |
| 2023-12-11 | Catherine Coste | Director | A | — | — |
| 2023-12-11 | ALLEN BARBIERI | Vice Chairman | A | — | — |
| 2023-12-11 | Jane Emerson | Director | A | — | — |
| 2023-12-11 | DAVID MOATAZEDI | Director | A | — | — |
| 2023-12-11 | Zackary S. Irani | Chief Executive Officer | A | — | — |
| 2023-05-26 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-05-12 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-05-12 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-05-10 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-05-05 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-05-01 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-04-27 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-04-10 | Gary Lu | Chief Financial Officer | A | — | — |
| 2023-01-31 | ALLEN BARBIERI | Executive Vice Chairman | Buy | — | — |
| 2023-01-30 | Catherine Coste | Director | Buy | — | — |
| 2023-01-26 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2023-01-25 | Zackary S. Irani | Chief Executive Officer | Buy | — | — |
| 2021-12-10 | Steven Sloan | Chief Financial Officer | A | — | — |
| 2021-12-10 | ALLEN BARBIERI | Director | A | — | — |
| 2021-12-10 | Catherine Coste | Director | A | — | — |
| 2021-12-10 | Jane Emerson | Director | A | — | — |
| 2021-12-10 | Zackary S. Irani | Chief Executive Officer | A | — | — |
| 2021-12-10 | Mark A Sirgo | Director | A | — | — |
| 2020-12-11 | Catherine Coste | Director | A | — | — |
| 2020-12-11 | Steven Sloan | Chief Financial Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 242,570 | — |
| — | Chief Financial Officer | 92,212 | — |
| — | Executive Vice Chairman | 73,542 | — |
| — | Chief Financial Officer | 59,375 | — |
| — | Director | 51,250 | — |
| — | Director | 40,625 | — |
| — | Director | 38,750 | — |
| — | Director | 19,500 | — |
| — | Director | 19,080 | — |
| — | Director | 17,237 | — |
| — | President | 10,875 | — |
| — | Director | 1,088 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BMRA quote page; the site-wide leaderboard is on the insider transactions hub.